AGLagilon health, inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Choppy, but holding above its 200-day average. Price is +53% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 2.8% since the previous count, up from 3.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AGL is trading
agilon health, inc. is +185% over the past year while the S&P 500 is +18%: 167 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +53%
vs 200-day average · a clear uptrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-09
- $82.66
- 1 monthS&P 500 +2.7%
- −11%
- 1 yearS&P 500 +18%
- +185%
- 5 yearsS&P 500 +88%
- −89%
- vs 50-day average$89.68
- −7.8%
- 52-week high
- $129.35
- 52-week low
- $7.91
- Annualised volatility
- 143%
| Year | Return |
|---|---|
| 2026 (year to date) | +380% |
| 2025 | −64% |
| 2024 | −85% |
| 2023 | −22% |
| 2022 | −40% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +7.9% |
| Feb | 5 | 2 of 5 | −2.5% |
| Mar | 5 | 3 of 5 | +5.9% |
| Apr | 5 | 2 of 5 | +43% |
| May | 6 | 4 of 6 | +33% |
| Jun | 6 | 5 of 6 | +6.3% |
| Jul | 6 | 3 of 6 | −1.4% |
| Aug | 6 | 0 of 6 | −18% |
| Sep | 6 | 2 of 6 | −7.4% |
| Oct | 6 | 2 of 6 | −12% |
| Nov | 5 | 0 of 5 | −20% |
| Dec | 5 | 3 of 5 | +5.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.